Found 0 matching trials
Concurrent Boost Radiotherapy
PHASE2The primary aim of this study is to evaluate the feasibility of delivering ...
Location
University Health Network, Princess Margaret Hospital
A Prospective Randomized Trial of Pre-Operative IMRT+Surgery Versus Surgery Alone For Primary Retroperitoneal Sarcoma
PHASE3This is a phase III clinical trial for patients with potentially completely...
Location
Memorial Sloan-Kettering Cancer Center
Postoperative Radiotherapy With Nimotuzumab ยฑ Benmelstobart in Intermediate-Risk Head and Neck Squamous Cell Carcinoma
PHASE2A multicenter, randomized, controlled, open-label, Phase II/III clinical tr...
Location
Multiple Locations
Treating Locally Advanced Rectal Cancer With TAS-102 Chemotherapy Plus Neoadjuvant Radiotherapy
PHASE2The goal of this Phase 2 trial is to evaluate a neoadjuvant treatment mode ...
Location
Cancer Center, Sun Yat-sen University
OPSCC N0 Nodal Control With Reduced IMRT
NAThe dose of radiation most commonly used to treat oropharyngeal cancer resu...
Location
University of Virginia Health System
Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCC
NAThis study is a phase III, multicenter, prospective randomized controlled c...
Location
The First Affiliated Hospital of Nanjing Medical University
Study Using Pharmacogenetics to Select Treatment for Head and Neck Cancer
PHASE2This is a study for patients with head and neck cancer who will be receivin...
Location
Multiple Locations
Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-IIIB Non-small Cell Lung Cancer
PHASE1This partially randomized phase I/II trial studies the side effects and bes...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
PHASE1This phase I trial studies the side effects and best dose of radiation ther...
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer
PHASE1This study will evaluate the safety of adding nivolumab to several chemothe...
Location
Stanford Cancer Institute